摘要
焦虑症是一种常见的精神障碍性疾病。DNA甲基化是焦虑症发展中关键的表观遗传学机制,其能够在不改变DNA序列的前提下改变遗传表型,并通过DNA甲基转移酶的作用在基因组CpG二核苷酸的胞嘧啶5号碳位共价键结合一个甲基基团,抑制基因转录、影响染色质结构和调节组蛋白修饰,从而影响基因表达。焦虑症动物模型的相关大脑区域中DNA甲基化水平发生改变,影响基因表达和神经递质调节等生物学过程,但DNA甲基化在焦虑中的作用机制尚不完全清楚。本文主要阐述脑内特定基因,如糖皮质激素受体(GR)基因、脑源性神经营养因子(BDNF)基因以及5-羟色胺(5-HT)相关基因的甲基化与焦虑症之间的关系,并总结研究进展和提出相应见解,旨在为焦虑症的预防和治疗提供理论依据。
Anxiety disorder is a common mental disorder.DNA methylation is a key epigenetic mechanism in the development of anxiety disorders,which can alter genetic expression without altering the DNA sequence and binds a methyl group to the cytosine 5 carbon of CpG dinucleotide through the action of DNA methyltransferase,thereby inhibiting gene transcription,affecting chromatin structure,and regulating histone modification in ways to affect gene expression.Animal models of anxiety disorders involve mechanisms by which altered levels of DNA methylation in relevant brain regions affect gene expression and regulate neurotransmitters.The mechanism of action of DNA methylation in anxiety is not fully understood.This paper focuses on the relationship between DNA methylation of brain specific genes,such as glucocorticoid receptor(GR),brain-derived neurotrophic factor(BDNF)and 5-hydroxytryptamine(5-HT)related gene and anxiety disorders,and summarizes the research and puts forward corresponding opinions,aiming at providing theoretical basis for the prevention and treatment of anxiety disorders.
作者
张文欣
闫文静
王月
刘怀玉
李米亚
何治
ZHANG Wen-Xin;YAN Wen-Jing;WANG Yue;LIU Huai-Yu;LI Mi-Ya;HE Zhi(Third-grade Pharmacological Laboratory on Traditional Chinese Medicine,State Administration of Traditional Chinese Medicine,China Three Gorges University,Yichang 443002,China;Health Medical College,China Three Gorges University,Yichang 443002,China;Jiaxing University School of Medicine,Jiaxing 314000,China)
出处
《生命科学》
CSCD
2024年第7期917-928,共12页
Chinese Bulletin of Life Sciences
基金
国家自然科学基金面上项目(82073824)。